Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Pfe crawled date : 2022 - 03 - 01 save search
Tarsier Pharma Adds Ocular Immunology Experts to Scientific Advisory Board
Published: 2022-03-01 (Crawled : 18:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
ocular immunology pharma
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
QTRX | $15.8 0.32% 0.32% 360K
|
Health Technology
|
| O: 3.95%
H: 6.39%
C: -6.56%
corporation results
Phase 3 CLOVER Trial for Pfizer’s Investigational Clostridioides Difficile Vaccine Indicates Strong Potential Effect in Reducing Duration and Severity of Disease Based on Secondary Endpoints
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
trial disease potential vaccine phase 3
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 60.78% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 900K
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.